Submission supported by data from INTEGUMENT-INFANT Phase 2 open-label study in infants aged 3 months to less than 24 months with mild to ...

The study1 by Emma Guttman-Yassky and colleagues represents an important and innovative contribution to the evolving treatment landscape of moderate-to-severe atopic dermatitis, particularly by ...

In this episode, the panel discusses the next wave of biologic development in atopic dermatitis, including bispecific ...

More severe atopic dermatitis increases the risk for sleep and memory disturbances among adults with atopic dermatitis.

Discover some of the new atopic dermatitis treatments in clinical development that could overcome existing challenges in the ...

Strong recommendation with high certainty of clinical evidence underscores proven efficacy, safety, and tolerability of ZORYVE cream as a ...

Site-specific involvement and history of conventional therapy use were associated with MDA at 52 weeks in patients with AD with early response.

What is contact dermatitis? Contact dermatitis is a reaction that occurs when something touches your skin and triggers a rash. The rash may appear right away or it could take some time to develop.

Adults with severe atopic dermatitis are susceptible to significant sleep and memory disorders, according to researchers from ...

Amlitelimab is safe and effective, with potentially progressive efficacy over time, for patients with moderate-to-severe atopic dermatitis.

Eighty-five percent of adults with atopic dermatitis also reported a sexual health disorder, but the frequency of these ...